Pfizer is a research-based biopharmaceutical company. Co. is engaged in discovering, developing, manufacturing and distributing of healthcare products, including medicines and vaccines. Co. manages its commercial operations through three businesses: Pfizer Biopharmaceuticals Group, which includes Oncology, Inflammation and Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine business units, as well as a hospital business unit; Upjohn, which includes Co.'s solid oral dose brands such as Lyrica, Lipitor, Norvasc, Celebrex, Viagra, and certain generic medicines; and Consumer Healthcare, which is an over-the-counter medicines business.
When researching a stock like Pfizer, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from PFE Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for PFE stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the PFE 200 day moving average ("PFE 200 DMA"), while one of the most popular "shorter look-backs" is the PFE 50 day moving average ("PFE 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Pfizer. |
Video: Technical Analysis